share_log

藥明巨諾-B：截至二零二四年四月三十日止月份之股份發行人的證券變動月報表

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

HKEX ·  May 7, 2024 18:09

Summary by Moomoo AI

藥明巨諾-B（JW Therapeutics）於2024年5月7日向香港交易及結算所有限公司提交了截至2024年4月30日的證券變動月報表。報告顯示，公司的法定/註冊股本結存維持在5,000,000,000股，面值0.00001美元，總額50,000美元，本月無變動。根據股份期權計劃，本月內已行使210,000股份期權，並因此發行新股份，獲得資金總額為2.1美元。此外，報告中提及的受限制股份單位計劃，本月內發行的新股份數目為1,203,121股。總計，本月普通股增加總額為1,413,121股。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
藥明巨諾-B（JW Therapeutics）於2024年5月7日向香港交易及結算所有限公司提交了截至2024年4月30日的證券變動月報表。報告顯示，公司的法定/註冊股本結存維持在5,000,000,000股，面值0.00001美元，總額50,000美元，本月無變動。根據股份期權計劃，本月內已行使210,000股份期權，並因此發行新股份，獲得資金總額為2.1美元。此外，報告中提及的受限制股份單位計劃，本月內發行的新股份數目為1,203,121股。總計，本月普通股增加總額為1,413,121股。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
JW Therapeutics filed with Hong Kong Trading and Settlement Limited on 7 May 2024 with Hong Kong Trading and Settlement Limited its Securities Monthly Change Report for the year ended 30 April 2024. The report showed that the company's regulated/registered capital deposit remained at 5,000,000,000 shares with a face value of $0.00001 for a total of $50,000, unchanged this month. Under the share option plan, 210,000 share options were exercised this month and as a result, new shares were issued for a total amount of $2.1. In addition, the restricted share plan referred to in the report amounts to 1,203,121 shares issued during the month. In total, ordinary shares increased this month to a total of 1,413,121 shares. The Company confirms that all securities issuance has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
JW Therapeutics filed with Hong Kong Trading and Settlement Limited on 7 May 2024 with Hong Kong Trading and Settlement Limited its Securities Monthly Change Report for the year ended 30 April 2024. The report showed that the company's regulated/registered capital deposit remained at 5,000,000,000 shares with a face value of $0.00001 for a total of $50,000, unchanged this month. Under the share option plan, 210,000 share options were exercised this month and as a result, new shares were issued for a total amount of $2.1. In addition, the restricted share plan referred to in the report amounts to 1,203,121 shares issued during the month. In total, ordinary shares increased this month to a total of 1,413,121 shares. The Company confirms that all securities issuance has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Latest Price
    LAEKNA-B
    02105
    -- 10.800
    IMMUNEONCO-B
    01541
    -- 5.130
    BIOSTAR PHARM-B
    02563
    -- 16.160
    HBM HOLDINGS-B
    02142
    -- 2.080
    IMMUNOTECH-B
    06978
    -- 2.320

    Unlock the Full List